California Apparel and Retail Sector Gains Legal Support Amidst Surge in Sustainability Mandates Qualcomm Gains Momentum as Investor Sentiment Shifts Toward AI Device Boom Auto Industry Faces Eighth Straight Monthly Sales Decline as EV Demand Wanes Amid Economic Pressure Professional Title Copper Tariff Speculation Resurfaces Disrupting Global Metal Flows MalaysiaJapan Hydrogen Project Faces ScaleBack Amid Funding Constraints Taiwan Semiconductor Manufacturing Stock Approaches Milestone Amid AI Demand Surge BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS Knowles Q1 2026 Earnings EPS Surges Past Estimates Stock Rises 4 CSTE Q1 2026 Earnings EPS Surpasses Estimates Despite Net Loss Hyliion Holdings Corp HYLN Q1 2026 Earnings Narrower Loss Fuels 42 Rally KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly MFICL Q1 2026 Earnings EPS Beat Supports Stable Performance Amid Steady Portfolio Marcus Millichap MMI Rises 242 as Real Estate Services Sector Gains Momentum BlackRock Enhanced Large Cap Core Fund CII Rises 163 as Price Approaches Key Resistance Level Geron Corporation GERN Edges Higher Testing Key Resistance After Modest Gains eBay Inc EBAY Holds Steady Near 115 as Support and Resistance Levels Tighten Nabors Industries NBR Slides 379 as Energy Sector Headwinds Intensify Micron Stock Surges After UBS Triples Price Target Sees AIDriven Transformation SOC Q1 2026 Earnings EPS Misses Estimates by Wide Margin No Revenue Reported Verra Mobility VRRM Plunges 70 Whats Behind the Sharp Decline SLSN Q1 2026 Earnings Narrow Loss Reported Amid Quiet Quarter VICI Properties Q1 2026 Earnings Strong EPS Beat Driven by Resilient Portfolio Performance GOOGL Q1 2026 Earnings EPS Misses Estimates as Revenue Uncertainty Weighs on Sentiment LSTA Q3 2025 Earnings Narrowerthanexpected Loss Highlights Operational Progress CLRB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue GXAI Q1 2026 Earnings EPS Misses Estimates as AI Development Continues Without Revenue AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs